Skip to content
Search

Latest Stories

Pharmacy teams encouraged to support PANORAMIC study

Pharmacy teams are being encouraged to support the ground-breaking Platform Adaptive trial of Novel antivirals for early treatment of Covid-19 In the Community (PANORAMIC) study by raising awareness among patients.

The study aims to find out whether new antiviral treatments can help Covid-19 patients avoid hospital admission and support a quicker recovery.


The PANORAMIC trial will allow researchers to gather data on the potential benefits of treatments to patients and will help the NHS to develop plans for rolling out the products to further patients in 2022.

Anyone over the age of 50 or between 18 to 49 with certain underlying health conditions can participate in the trial after receiving a positive PCR or lateral flow test result for Covid-19.

People who wish to participate in the trial can sign up themselves through the study’s website and may be contacted by a member of the clinical team in a general practice that has been set up to deliver the PANORAMIC trial.

They can even participate from their own home from anywhere in the UK, requiring no face-to-face visits.

PSNC suggestions

To support the trial, the Pharmaceutical Services Negotiating Committee (PSNC) suggested pharmacy teams to display the poster about the study in their pharmacy and encourage those who have tested positive for Covid-19 to come forward.

They could also highlight the study while supplying lateral flow tests to people or use social media to create awareness, the negotiator said.

Bradford Univ Pic 2 Professor Mahendra G Patel

Commenting on the importance of recruiting a diverse range of people to the trial and pharmacy’s role in this, professor Mahendra G Patel, the PANORAMIC trial’s Pharmacy, and Inclusion and Diversity lead, University of Oxford said: “It’s important that we continue to recruit patients from all backgrounds and from different ethnic origins as well as those living in areas of high deprivation in order to be inclusive and representative of the British diaspora.

“We must try to make more effective use all our networks across different settings and organisations to HELP get behind this on a priority basis, so that we can quickly establish how these new antivirals can be effective and made available to those who need it the most.”

So far, more than 9,000 vulnerable people have enrolled for the PANORAMIC study, but more volunteers are urgently needed to come forward and join the trial, he added.

Professor Patel said that pharmacy can play a crucial role in recruiting volunteers due to its vast network through which it can help reach out to communities from all backgrounds.

Lauding the efforts of community pharmacy during the pandemic, he said, “it has relentlessly provided during the pandemic, overcoming unbelievable levels of difficulties and challenges.

“I feel once again, we as pharmacy can play our part in this pandemic to help in the search for effective treatment of Covid-19 in the community through supporting public health and reducing health inequalities by making the PANORAMIC trial as visible as possible and accessible to all.

“Pharmacy has not only kept us going during the pandemic, but it can also play a vital role in helping us all to come out of it. Let’s make history together, for us, our loved ones and everyone everywhere.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less